Clinical characteristics | Items | Cases | HR (95% CI) | P value |
---|---|---|---|---|
Gender | Female | 236 | 2.05 (1.44–2.92) | 4.9e−05 |
Male | 545 | 1.52 (1.22–1.89) | 0.00015 | |
Treatment | Surgery alone | 380 | 1.71 (1.28–2.29) | 0.00023 |
5 FU based | 153 | 0.65 (0.46–0.92) | 0.014 | |
Other adjuvant | 76 | 2.82(1.17–6.79) | 0.015 | |
HER2 status | Negative | 532 | 1.58(1.25–1.99) | 9.4e−05 |
Positive | 344 | 1.58 (1.22–2.05) | 0.00049 | |
Stage | StageI | 67 | 0.45 (0.17–1.24) | 0.11 |
StageII | 140 | 0.62(1.34–1.14) | 0.12 | |
StageIII | 305 | 1.89(1.41–2.53) | 1.4e−05 | |
StageIV | 148 | 1.87(1.27–2.77) | 0.0014 | |
Stage T | T2 | 241 | 1.84(1.18–2.86) | 0.0061 |
T3 | 204 | 1.87(1.32–2.63) | 3.0e−04 | |
T4 | 38 | 1.91(0.82–4.47) | 0.13 | |
Stage N | N0 | 74 | 1.67(0.73–3.83) | 0.22 |
N (1 + 2 + 3) | 422 | 2.36(1.81–3.09) | 8.2e−11 | |
N1 | 225 | 2.31(1.53–3.48) | 3.8e−05 | |
N2 | 121 | 2.92(1.84–4.63) | 1.9e-6 | |
N3 | 76 | 2.27(1.31–3.91) | 0.0026 | |
Stage M | M0 | 444 | 2.14(1.62–2.83) | 3.9e-8 |
M1 | 56 | 1.84(1.01–3.33) | 0.042 | |
Lauren classification | Instestinal | 320 | 2.49 (1.8–3.46) | 1.6e-8 |
Diffuse | 241 | 1.89 (1.34–2.66) | 0.00023 | |
Differentiation | Mixed | 33 | 4.55 (1.56–13.32) | 0.0025 |
Poorly | 165 | 1.79 (1.16–2.75) | 0.0074 | |
Moderately | 67 | 2.71 (1.35–5.44) | 0.0036 | |
Well | 32 | 4.36 (1.8–10.54) | 4.0e-04 |